Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UC-MSCs for Acute Myocardial Infarction
NCT04340609Phase 2Completed
- Sponsor
- Prodia Stem Cell Indonesia
- Start
- Mar 2019
- Primary completion
- Apr 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of human umbilical cord mesenchymal stem cells in acute myocardial infarction (AMI), sponsored by Prodia Stem Cell Indonesia. Started Mar 2019; status: completed.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT04340609.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04340609.